StockData
Harvard Bioscience Inc logo

Harvard Bioscience Inc (HBIO) stock

HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3040% above fair value
$9.08+0.17 (+1.91%)

Close on Nov 17, 2026Market cap $41.33MP/E –Yield –

Harvard Bioscience cash

Cash and short-term investments held at the end of each period.

Harvard Bioscience's cash was $6.50M at Jun 30, 2026. For fiscal 2025 it was $8.61M, up 109.7% from the year before. Over ten years it grew 2.5% a year on average. The highest annual figure on record is $25.77M in fiscal 2013.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$8.61M+109.7%
FY2024Dec 31, 2024$4.11M-4.1%
FY2023Dec 31, 2023$4.28M-5.0%
FY2022Dec 31, 2022$4.51M-42.4%
FY2021Dec 31, 2021$7.82M-6.0%
FY2020Dec 31, 2020$8.32M-0.2%
FY2019Dec 31, 2019$8.34M+2.0%
FY2018Dec 31, 2018$8.17M+42.6%
FY2017Dec 31, 2017$5.73M+2.4%
FY2016Dec 31, 2016$5.60M-17.0%
FY2015Dec 31, 2015$6.74M-52.3%
FY2014Dec 31, 2014$14.13M-45.2%
FY2013Dec 31, 2013$25.77M+24.6%
FY2012Dec 31, 2012$20.68M+15.4%
FY2011Dec 31, 2011$17.92M-9.1%
FY2010Dec 31, 2010$19.70M+18.8%
FY2009Dec 31, 2009$16.59M+21.1%
FY2008Dec 31, 2008$13.70M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$6.50M-12.6%
Q1 FY2026Mar 31, 2026$7.10M+28.0%
Q4 FY2025Dec 31, 2025$8.61M+109.7%
Q3 FY2025Sep 30, 2025$6.82M+49.2%
Q2 FY2025Jun 30, 2025$7.44M+83.8%
Q1 FY2025Mar 31, 2025$5.55M+30.3%
Q4 FY2024Dec 31, 2024$4.11M-4.1%
Q3 FY2024Sep 30, 2024$4.57M-14.4%
Q2 FY2024Jun 30, 2024$4.05M-6.4%
Q1 FY2024Mar 31, 2024$4.26M+12.3%
Q4 FY2023Dec 31, 2023$4.28M-5.0%
Q3 FY2023Sep 30, 2023$5.34M+3.8%
Q2 FY2023Jun 30, 2023$4.32M+1.5%
Q1 FY2023Mar 31, 2023$3.79M-30.3%
Q4 FY2022Dec 31, 2022$4.51M-42.4%
Q3 FY2022Sep 30, 2022$5.14M-7.3%
Q2 FY2022Jun 30, 2022$4.26M-31.7%
Q1 FY2022Mar 31, 2022$5.43M-6.6%
Q4 FY2021Dec 31, 2021$7.82M-6.0%
Q3 FY2021Sep 30, 2021$5.55M+97.7%
Q2 FY2021Jun 30, 2021$6.24M+137.2%
Q1 FY2021Mar 31, 2021$5.82M-1.1%
Q4 FY2020Dec 31, 2020$8.32M-0.2%
Q3 FY2020Sep 30, 2020$2.81M-59.0%
Q2 FY2020Jun 30, 2020$2.63M-46.7%
Q1 FY2020Mar 31, 2020$5.88M+16.9%
Q4 FY2019Dec 31, 2019$8.34M+2.0%
Q3 FY2019Sep 30, 2019$6.85M+2.8%
Q2 FY2019Jun 30, 2019$4.93M-12.3%
Q1 FY2019Mar 31, 2019$5.03M-16.0%
Q4 FY2018Dec 31, 2018$8.17M+42.6%
Q3 FY2018Sep 30, 2018$6.66M+14.1%
Q2 FY2018Jun 30, 2018$5.62M+19.1%
Q1 FY2018Mar 31, 2018$5.99M+30.3%
Q4 FY2017Dec 31, 2017$5.73M+2.4%
Q3 FY2017Sep 30, 2017$5.84M+9.2%
Q2 FY2017Jun 30, 2017$4.72M–
Q1 FY2017Mar 31, 2017$4.60M–
Q4 FY2016Dec 31, 2016$5.60M–
Q3 FY2016Sep 30, 2016$5.35M–

More Harvard Bioscience figures

See a number that looks wrong?